204 related articles for article (PubMed ID: 22126332)
1. Antifibrotic effects of curcumin are associated with overexpression of cathepsins K and L in bleomycin treated mice and human fibroblasts.
Zhang D; Huang C; Yang C; Liu RJ; Wang J; Niu J; Brömme D
Respir Res; 2011 Nov; 12(1):154. PubMed ID: 22126332
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of cathepsin K in mice decreases collagen deposition and lung resistance in response to bleomycin-induced pulmonary fibrosis.
Srivastava M; Steinwede K; Kiviranta R; Morko J; Hoymann HG; Länger F; Buhling F; Welte T; Maus UA
Respir Res; 2008 Jul; 9(1):54. PubMed ID: 18638383
[TBL] [Abstract][Full Text] [Related]
3. Antifibrotic effects of cyclosporine A on TGF-β1-treated lung fibroblasts and lungs from bleomycin-treated mice: role of hypoxia-inducible factor-1α.
Yamazaki R; Kasuya Y; Fujita T; Umezawa H; Yanagihara M; Nakamura H; Yoshino I; Tatsumi K; Murayama T
FASEB J; 2017 Aug; 31(8):3359-3371. PubMed ID: 28446589
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Wnt/β-catenin signaling suppresses bleomycin-induced pulmonary fibrosis by attenuating the expression of TGF-β1 and FGF-2.
Chen X; Shi C; Meng X; Zhang K; Li X; Wang C; Xiang Z; Hu K; Han X
Exp Mol Pathol; 2016 Aug; 101(1):22-30. PubMed ID: 27112840
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of cathepsin K during silica-induced lung fibrosis and control by TGF-beta.
van den Brûle S; Misson P; Bühling F; Lison D; Huaux F
Respir Res; 2005 Jul; 6(1):84. PubMed ID: 16045809
[TBL] [Abstract][Full Text] [Related]
6. The effect of cathepsin K deficiency on airway development and TGF-β1 degradation.
Zhang D; Leung N; Weber E; Saftig P; Brömme D
Respir Res; 2011 May; 12(1):72. PubMed ID: 21627832
[TBL] [Abstract][Full Text] [Related]
7. Tenofovir alafenamide fumarate attenuates bleomycin-induced pulmonary fibrosis by upregulating the NS5ATP9 and TGF-β1/Smad3 signaling pathway.
Li L; Zhao J; Zhou L; Chen J; Ma Y; Yu Y; Cheng J
Respir Res; 2019 Jul; 20(1):163. PubMed ID: 31331325
[TBL] [Abstract][Full Text] [Related]
8. Lanatoside C protects mice against bleomycin-induced pulmonary fibrosis through suppression of fibroblast proliferation and differentiation.
Nie Y; Zhang D; Jin Z; Li B; Wang X; Che H; You Y; Qian X; Zhang Y; Zhao P; Chai G
Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):575-586. PubMed ID: 30854687
[TBL] [Abstract][Full Text] [Related]
9. Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway.
Jin YK; Li XH; Wang W; Liu J; Zhang W; Fang YS; Zhang ZF; Dai HP; Ning W; Wang C
Chin Med J (Engl); 2018 Aug; 131(16):1917-1925. PubMed ID: 30082522
[TBL] [Abstract][Full Text] [Related]
10. Curcumin inhibits the TGF-β1-dependent differentiation of lung fibroblasts via PPARγ-driven upregulation of cathepsins B and L.
Saidi A; Kasabova M; Vanderlynden L; Wartenberg M; Kara-Ali GH; Marc D; Lecaille F; Lalmanach G
Sci Rep; 2019 Jan; 9(1):491. PubMed ID: 30679571
[TBL] [Abstract][Full Text] [Related]
11. Paroxetine protects against bleomycin-induced pulmonary fibrosis by blocking GRK2/Smad3 pathway.
Zhao K; Nie H; Tang Z; Chen G; Huang J
Aging (Albany NY); 2023 Oct; 15(19):10524-10539. PubMed ID: 37815883
[TBL] [Abstract][Full Text] [Related]
12. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
Mou F; Mou C
Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
[TBL] [Abstract][Full Text] [Related]
13. Antiflammin-1 attenuates bleomycin-induced pulmonary fibrosis in mice.
Liu W; Wan J; Han JZ; Li C; Feng DD; Yue SJ; Huang YH; Chen Y; Cheng QM; Li Y; Luo ZQ
Respir Res; 2013 Oct; 14(1):101. PubMed ID: 24098933
[TBL] [Abstract][Full Text] [Related]
14. Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury.
Smith MR; Gangireddy SR; Narala VR; Hogaboam CM; Standiford TJ; Christensen PJ; Kondapi AK; Reddy RC
Am J Physiol Lung Cell Mol Physiol; 2010 May; 298(5):L616-25. PubMed ID: 20061443
[TBL] [Abstract][Full Text] [Related]
15. Anti-fibrotic effect of iguratimod on pulmonary fibrosis by inhibiting the fibroblast-to-myofibroblast transition.
Lin H; Wu C; Zhu F; Zhang G; Xie Y; Cui Y; Dong G; Zhang X
Adv Med Sci; 2020 Sep; 65(2):338-347. PubMed ID: 32590154
[TBL] [Abstract][Full Text] [Related]
16. Glycosyltransferases and glycosaminoglycans in bleomycin and transforming growth factor-β1-induced pulmonary fibrosis.
Venkatesan N; Tsuchiya K; Kolb M; Farkas L; Bourhim M; Ouzzine M; Ludwig MS
Am J Respir Cell Mol Biol; 2014 Mar; 50(3):583-94. PubMed ID: 24127863
[TBL] [Abstract][Full Text] [Related]
17. Anti-fibrotic effect of thalidomide through inhibiting TGF-beta-induced ERK1/2 pathways in bleomycin-induced lung fibrosis in mice.
Choe JY; Jung HJ; Park KY; Kum YS; Song GG; Hyun DS; Park SH; Kim SK
Inflamm Res; 2010 Mar; 59(3):177-88. PubMed ID: 19757088
[TBL] [Abstract][Full Text] [Related]
18. Protective role of rhapontin in experimental pulmonary fibrosis in vitro and in vivo.
Tao L; Cao J; Wei W; Xie H; Zhang M; Zhang C
Int Immunopharmacol; 2017 Jun; 47():38-46. PubMed ID: 28364627
[TBL] [Abstract][Full Text] [Related]
19. Lysine-specific demethylase-1 regulates fibroblast activation in pulmonary fibrosis via TGF-β1/Smad3 pathway.
Pan X; Li J; Tu X; Wu C; Liu H; Luo Y; Dong X; Li X; Pan LL; Sun J
Pharmacol Res; 2020 Feb; 152():104592. PubMed ID: 31830521
[TBL] [Abstract][Full Text] [Related]
20. The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice.
Okazaki H; Sato S; Koyama K; Morizumi S; Abe S; Azuma M; Chen Y; Goto H; Aono Y; Ogawa H; Kagawa K; Nishimura H; Kawano H; Toyoda Y; Uehara H; Kouji H; Nishioka Y
Exp Lung Res; 2019 Sep; 45(7):188-199. PubMed ID: 31298961
[No Abstract] [Full Text] [Related]
[Next] [New Search]
